Short-term evaluation of renal markers in overweight adult cats

Vet Med Sci. 2023 Mar;9(2):572-578. doi: 10.1002/vms3.1021. Epub 2023 Jan 14.

Abstract

Background: Obesity has been proposed as an independently risk factor for chronic kidney disease (CKD) in people, but its role in feline kidney function is unknown.

Objective: Obesity has been proposed as an independent risk factor for chronic kidney disease (CKD) in people, but its role in feline kidney function is unknown. This study prospectively evaluated the effect of overweight on the concentration of symmetric dimethylarginine (SDMA) and creatinine in a cohort of healthy cats.

Methods: Forty healthy adult cats were included, 14 with a body condition score (BCS) = 5 and 26 with a BCS > 5. Cats were examined every 6 months, for up to 12 months. SDMA and creatinine were measured at baseline and follow-up.

Results: No effect was found for time of follow-up (p = 0.072), overweight (p = 0.9442) or their interaction (p = 0.902) on SDMA, though a significant effect was found for age (p < 0.001) [older cats showing higher SDMA] and sex (p = 0.007) [male cats showing higher SDMA]. Regarding creatinine, no effect for time (p = 0.671), age (p = 0.061), overweight (p = 0.319) or the latter's interaction (p = 0.386) were found.

Conclusions: In the short term, markers of renal function did not show an association with overweight. The role of obesity in feline kidney function still warrants further evaluation.

Keywords: chronic kidney disease; creatinine; obesity; symmetric dimethylarginine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Biomarkers
  • Cat Diseases*
  • Cats
  • Creatinine
  • Kidney / physiology
  • Male
  • Obesity / veterinary
  • Overweight / veterinary
  • Renal Insufficiency, Chronic* / veterinary

Substances

  • Creatinine
  • Biomarkers